YZ
Yun Zhong Wedbush Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$12.5B
| $205.91 | $220 |
7%
upside
| Outperform | 28 days ago |
|
2
Wave Life Sciences
WVE
$1.32B
| $8.29 | $18 |
117%
upside
| Outperform | 2 months ago |
|
3
Keros Therapeutics
KROS
$632M
| $15.55 | $15 |
4%
downside
| Neutral | 3 months ago |
|
4
Rocket Pharmaceuticals
RCKT
$353M
| $3.27 | $32 |
879%
upside
| Outperform | 3 months ago |
|
5
Protagonist Therapeutics
PTGX
$3.77B
| $60.53 | $70 |
16%
upside
| Outperform | 5 months ago |
|
6
MoonLake Immunotherapeutics
MLTX
$3.78B
| $59.45 | $73 |
23%
upside
| Outperform | 10 months ago |
|
7
Rezolute
RZLT
$696M
| $8 | $12 |
50%
upside
| Outperform | 10 months ago |
|
8
Anavex Life Sciences
AVXL
$808M
| $9.41 | $28 |
198%
upside
| Buy | 2 years ago |
|
9
Amicus Therapeutics
FOLD
$2.47B
| $8 | $16 |
100%
upside
| Buy | 2 years ago |
|
10
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $160 |
755%
upside
| Buy | 2 years ago |
|
|
11
Rocket Pharmaceuticals
RCKT
$353M
| $3.27 | $35 |
970%
upside
| Buy | 2 years ago |
|
12
uniQure
QURE
$986M
| $17.97 | $46 |
156%
upside
| Buy | 4 years ago |
|
|
MREO
13
Mereo BioPharma
MREO
$281M
| $1.77 | $10 |
465%
upside
| Buy | 4 years ago |
|